Glioma Susceptibility 2; Glm2

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Glioma Susceptibility 2; Glm2

PTEN

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Glioma Susceptibility 2; Glm2

Seizures
Neoplasm
Headache
Abnormality of the nervous system
Focal-onset seizure
Dysphasia
Meningioma
Glioma

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Glioma Susceptibility 2; Glm2 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
PTEN Comprehensive - Sequence & Deletion/Duplication Analysis. By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
PTEN Deletion/Duplication Analysis. By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
PTEN Deletion/Duplication Analysis (Prenatal Diagnosis). By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
PTEN Sequence Analysis. By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
PTEN Sequence Analysis (Familial Mutation/Variant Analysis). By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
PTEN Sequence Analysis (Prenatal Diagnosis). By Baylor Miraca Genetics Laboratories (United States). PTEN Specificity 100 % Genes 100 %
Hereditary High Risk Breast Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN Specificity 15 % Genes 100 %
Hereditary High Risk Breast Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN Specificity 15 % Genes 100 %

You can get up to 416 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20 SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1 HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3 BARDET-BIEDL SYNDROME 16; BBS16 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S; LGMD2S CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE